Autor(es): Gonçalves, E ; Fontes, F ; Rodrigues, JR ; Calisto, R ; Bento, MJ ; Lunet, N ; Morais, S
Data: 2024
Identificador Persistente: https://hdl.handle.net/10216/156385
Origem: Repositório Aberto da Universidade do Porto
Autor(es): Gonçalves, E ; Fontes, F ; Rodrigues, JR ; Calisto, R ; Bento, MJ ; Lunet, N ; Morais, S
Data: 2024
Identificador Persistente: https://hdl.handle.net/10216/156385
Origem: Repositório Aberto da Universidade do Porto
"Purpose To estimate the incidence rate of second primary cancers (SPCs) and the cumulative incidence of metachronous [diagnosed > 2 months after a first primary cancer (FPC)] SPCs in patients with a breast FPC, and to compare the incidence of SPC [overall, synchronous (≤ 2 months of the FPC) and metachronous] with that expected in the general female population. Methods A cohort of patients with a breast FPC from the North Region Cancer Registry of Portugal, diagnosed in 2000–2010 (n = 15,981), was followed to 31 December 2015 for synchronous and metachronous SPCs. Cumulative incidence of metachronous SPCs considering death as a competing event, and incidence rates and standardized incidence ratios of SPCs were estimated. Results The diagnosis of an SPC occurred in 1229 (7.7%) of patients with a breast FPC. SPCs occurred mainly in the breast, followed by digestive organs, lung, thyroid, and female genital organs. Globally, patients with a breast FPC had a higher incidence for all types of cancer compared to the general female population, and in particular for cancers of the breast, stomach, colon, lung, lymphoma, uterus, and ovary. The 10-year cumulative incidence of metachronous SPCs following a breast FPC was 6.6% and the corresponding 10-year cumulative mortality was 26.2%. Conclusion In Portugal, patients with a breast FPC have a higher incidence of cancer compared to the general female population, highlighting important aspects of care, surveillance, and counselling among this growing number of patients."